American Financial Group’s ALX Oncology ALXO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-5,613
Closed -$415K 91
2021
Q3
$415K Hold
5,613
0.11% 74
2021
Q2
$307K Buy
+5,613
New +$336K 0.08% 80

Other funds holding ALXO

American Financial Group's ALXO Position: Q4 2021 in Review

American Financial Group sold out of ALX Oncology (ALXO) in Q4 2021, closing a stake of 5,613 shares — an estimated $415K sold.

American Financial Group first reported a position in ALXO in Q2 2021 and held it in 2 quarters. The position peaked at $415K in Q3 2021. 108 funds tracked by Wall St. Rank hold ALXO as of Q4 2021.

  • American Financial Group reported no remaining ALX Oncology position as of Q4 2021 after selling out during the quarter.
  • American Financial Group sold 5,613 ALX Oncology shares in Q4 2021, an estimated $415K.
  • American Financial Group first reported a position in ALX Oncology in Q2 2021 and held it in 2 quarters.
  • American Financial Group's ALX Oncology position peaked at $415K in Q3 2021.
  • 108 funds tracked by Wall St. Rank held ALX Oncology as of Q4 2021.

Based on American Financial Group's 13F filing for Q4 2021, filed 10 Feb 2022.